All Phenotypes Adck2<tm1(KOMP)Vlcg> MGI Mouse

abnormal adipose tissue amount ( J:280282 )

• visceral fat accumulation

• 12 month old mice show poorer coordination on a rotarod

• however, mice show unaltered nociceptive response in the hot-plate test, normal fear-conditioning, and only a tendency toward more extensive exploratory behavior

decreased grip strength ( J:280282 )

• mice show a decline in two and four limb grip strength tests

• mice supplemented with CoQ10 show improved grip strength

impaired exercise endurance ( J:280282 )

• 12 month old mice show reduced overall endurance, as seen by shorter running distance on a treadmill due to exhaustion

• mice supplemented with CoQ10 show improvement in treadmill endurance exercise time

abnormal mitochondrial physiology ( J:280282 )

• MEFs show a decrease in mitochondrial complexes III, II+III, and IV activities

• mitochondrial complex I+III and II+III activities are decreased in skeletal muscle, but the activities of the individual complexes are normal

• mitochondrial complex I, II, and I+III activities are higher in kidney mitochondria, while those of complex III, IV, and II+III are not affected

• oxygen consumption rate shows a difference in basal and maximum respiration in MEFs when glucose is used as a substrate

• however, mitochondrial respiratory complexes are unaffected in the brain and liver

increased mitochondrial fission ( J:280282 )

• succinate dehydrogenase and cytochrome c oxidase staining are increased in muscle fibers indicating mitochondrial proliferation

decreased fatty acid beta-oxidation ( J:280282 )

• mice show a decrease in mitochondrial fatty acid beta-oxidation

• MEFs do not show increased proliferation when fatty acids are added to medium at low glucose concentrations as is seen in wild-type MEFs and addition of fatty acids to glucose-free medium causes more than 50% growth arrest compared to wild-type cells

• palmitate-dependent oxygen consumption rate is decreased in permeabilized MEFs compared to wild-type cells

• circulating concentrations of beta-hydroxybutyrate and free carnitine are reduced

slow postnatal weight gain ( J:280282 )

• pups weight less at weaning than wild-type pups

• however, mice show a trend toward greater weight gain with age and no difference in body weight was seen at later time points

impaired exercise endurance ( J:280282 )

• 12 month old mice show reduced overall endurance, as seen by shorter running distance on a treadmill due to exhaustion

• mice supplemented with CoQ10 show improvement in treadmill endurance exercise time

abnormal homeostasis ( J:280282 )

• mice show higher oxygen consumption, carbon dioxide production, and respiratory exchange ratio, indicating a greater use of carbohydrates in mutants compared to a consumption of a mix of fat and carbohydrates by wild-type mice

decreased fatty acid beta-oxidation ( J:280282 )

• mice show a decrease in mitochondrial fatty acid beta-oxidation

• MEFs do not show increased proliferation when fatty acids are added to medium at low glucose concentrations as is seen in wild-type MEFs and addition of fatty acids to glucose-free medium causes more than 50% growth arrest compared to wild-type cells

• palmitate-dependent oxygen consumption rate is decreased in permeabilized MEFs compared to wild-type cells

• circulating concentrations of beta-hydroxybutyrate and free carnitine are reduced

decreased circulating carnitine level ( J:280282 )

• circulating concentrations of free carnitine are reduced

increased circulating lactate level ( J:280282 )

• increase in plasma lactate

• mice supplemented with CoQ10 show a decrease in plasma lactate levels

decreased circulating free fatty acids level ( J:280282 )

• decrease of free fatty acids such as linoleic, myristic, and palmitic in plasma

abnormal enzyme/coenzyme level ( J:280282 )

• MEFs show a reduction in CoQ9 and CoQ10 levels and in their biosynthetic rates

• CoQ9 and CoQ10 levels are decreased in skeletal muscle and a downward trend is seen in the heart and liver, but not in the brain or kidney

increased carbon dioxide production ( J:280282 )

increased oxygen consumption ( J:280282 )

increased respiratory quotient ( J:280282 )

increased fatty acids level ( J:280282 )

• circulating short- and long-chain fatty acid levels are increased

increased liver free fatty acids level ( J:280282 )

• accumulation of free fatty acids such as linoleic, myristic, and palmitic in tissues (especially stearic acid in the liver)

decreased glycerol level ( J:280282 )

organic aciduria ( J:280282 )

• urinary excretion of organic acids, including lactate, malate, fumarate, alpha-ketoglutarate, succinate, adipic acid, ethylmalonic acid, and hexanoylglycine, is increased

increased liver free fatty acids level ( J:280282 )

• accumulation of free fatty acids such as linoleic, myristic, and palmitic in tissues (especially stearic acid in the liver)

macrovesicular hepatic steatosis ( J:280282 )

• liver shows accumulation of large lipid droplets in periportal and perivenular hepatocytes

increased variability of skeletal muscle fiber size ( J:280282 )

• gastrocnemius muscle shows a mild variation in fiber size and some fibers appear as ragged red fibers

abnormal muscle physiology ( J:280282 )

• accumulation of pyruvate and lactate in plasma and skeletal muscle

• succinate dehydrogenase and cytochrome c oxidase staining are increased in muscle fibers indicating mitochondrial proliferation

organic aciduria ( J:280282 )

• urinary excretion of organic acids, including lactate, malate, fumarate, alpha-ketoglutarate, succinate, adipic acid, ethylmalonic acid, and hexanoylglycine, is increased

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
mitochondrial myopathy		DOID:699	OMIM:251900	J:280282

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/09/2024 MGI 6.23